[1]廖安燕,王俊杰.持续低剂量率照射治疗前列腺癌的生物学效应[J].国际放射医学核医学杂志,2005,29(4):190-192,封三.
　LIAO An-yan,WANG Jun-jie.The biological effect of continuous low-dose rate irradiation for prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):190-192,封三.
点击复制

持续低剂量率照射治疗前列腺癌的生物学效应(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
29
期数:
2005年第4期
页码:
190-192,封三
栏目:
放射医学
出版日期:
1900-01-01

文章信息/Info

Title:
The biological effect of continuous low-dose rate irradiation for prostate cancer
作者:
廖安燕;  王俊杰
100083 北京, 北京大学第三医院肿瘤治疗中心
Author(s):
LIAO An-yan;  WANG Jun-jie
Cancer Center, Peking University Third Hospital, Beijing 100083, China
关键词:
低剂量率照射; 前列腺癌; 生物学效应
Keywords:
low-dose rate irradiation; prostate cancer; biological effect
分类号:
Q345.2;R817.5
摘要:
持续低剂量率照射在前列腺癌的临床治疗方面已经积累了大量的经验。对持续低剂量率照射的生物学效应研究表现在以下几个方面:①反剂量率;②辐射敏感性;③凋亡和凋亡相关蛋白表达;④细胞周期及周期相关蛋白表达;⑤癌相关修复基因表达。
Abstract:
The clinic work of low-dose irradiation in the prostate cancer has already accumulated a large amont of experience. Studied on the biological effect of continuous low-dose rate was shown in the following several aspects:① the inverse dose rate effect; ② radio sensitivity; ③ apoptosis and relevant protein expression of apoptosis; ④ cell cycle and relevant protein expression of cell cycle; ⑤ repair gene cancer.

参考文献/References:

1 Grimm PD, Blasko JC, Sylvester JE, et al. 10-year biochemical(prostate specific antigen) control of prostate cancer with 125I brachy therapy[J]. Int J Radiat Oncol Biol Phys, 2001, 51(1):31-40.
2 Ragde H, Korb LJ, Elgamal AA, et al. Modern prostate brachytherapy:postate specific antigen results in 219 patients with up to 12years of observed follow-up[J]. Cancer, 2000, 89(1):135-141.
3 Merrick GS, Butler WM, Galbreath RW, et al. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer[J]. Int J Radiat Oncol Biol Phys, 2001,51(1):41-48.
4 王俊杰,黄毅,冉维强,等.经会阴超声引导放射性125I粒子组织间近距离治疗睾丸切除术后复发前列腺癌[J].肿瘤防治杂志,2003,10(8):962-964.
5 王俊杰,黄毅,冉维强,等.放射性粒子组织间近距离治疗肿瘤近期疗效[J].中国微创外科杂志,2003,3(1):148-149.
6 King CR, Dipetrillo TA, Wazer DE. Optimal radiotherapy for prostate cancer:predictions for conventional external beam, IMRT,and brachytherapy from radiobiologic models[J]. Int J Radiat Oncol Biol Phys, 2001,46(1):165-172.
7 王俊杰,黄毅,冉维强,等.放射性粒子组织间近距离治疗肿瘤[M].第2版,北京:北京大学医学出版社,2004.20-24.
8 Mitchell CR, Folkard M, Joiner MC. Effects of exposure to lowdose-rate 60Co gamma rays on human tumor sells in vitro[J]. Radiat Res, 2002, 158(3):311-318.
9 Deweese TL, shipman JM, Dillehay LE, et al. Sensitivity of human prostatic carcinoma cell lines to low close rate radiation exposure[J]. J Wrol, 1998, 159(5):591-597.
10 Kroger LA, Denardo GL, Gumer PH, et al. Apoptosis-related gene and protein expression in human lymphoma xenografts(Raji) after low dose rate radiation using 67 Cu-217-BAT-Lym-l radioimmunotherapy[J]. Cancer Biother Radiopharm, 2001, 16(3):213-225.
11 Szostak M J, Kaur P, Amin P, et al. Apoptosis and bcl-2 expression in prostate cancer:significance in clinical outcome after brachytheray[J]. J Urol, 2001, 165(6 Pt 1):2126-2130.
12 于洪升,黄从合,.低剂量辐射对肿瘤细胞凋亡、细胞周期以及凋亡相关蛋白bcl-2的影响[J].中华放射医学与防护杂志,2003,23(3):171-173.
13 Armpilia CI, Dale RG, Coles IP, et al. The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy in plants[J]. Int J Radiat Oncol Biol Phys, 2003, 55(2):378-385.
14 Dicker AP, Lincc J, Leeper DB, et al. Isotope selection for permanent prostate implants. An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry[J]. Semin Urol Oncol, 2000,18(2):152-159.
15 Yacoub A, Mckinstry R, Hinman D, et al. Epidermal growth factor and ionizing radiation up-regulate the DNA repair gengs XRCC1and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling[J]. Radiat Res, 2003, 159(2):439-452.

相似文献/References:

[1]郝玉美,贺欣,宋娜玲.前列腺癌干细胞分离方法研究进展[J].国际放射医学核医学杂志,2013,37(5):296.[doi:10.3760/cma.j.issn.1673-4114.2013.05.011]
　HAO Yu-mei,HE Xin,SONG Na-ling.Advanced research on separating prostate cancer stem cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):296.[doi:10.3760/cma.j.issn.1673-4114.2013.05.011]
[2]秦岚.前列腺癌近距离放射治疗的进展[J].国际放射医学核医学杂志,2005,29(4):159.
　QIN Lan.Evolution of brachytherapy for prostate carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):159.
[3]王俊杰.放射性粒子近距离治疗前列腺癌:临床篇[J].国际放射医学核医学杂志,2002,26(3):101.
　WANG Jun-jie.Radioactive seed implantation treatment for prostate carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(4):101.
[4]王宇.间质植入近距离照射治疗前列腺癌[J].国际放射医学核医学杂志,2001,25(5):233.
　WANG Yu.Interstitial implantation brachytherapy for the treatment of prostate carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(4):233.
[5]陈立波.钠/碘同向转运体与放射性碘治疗[J].国际放射医学核医学杂志,2001,25(6):258.
　CHEN Li-bo.The sodium/iodide symporter and radioiodide therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(4):258.
[6]许杨.前列腺特异性抗原及其临床应用[J].国际放射医学核医学杂志,2000,24(5):201.
　XU Yang.Prostate specific antigen and its clinical apptication[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(4):201.
[7]陆汉魁,林祥通,刘家慧,等.乳腺癌和前列腺癌的类固醇受体显像研究现状[J].国际放射医学核医学杂志,1996,20(3):106.

备注/Memo

备注/Memo:
收稿日期:2005-01-09。
更新日期/Last Update: 1900-01-01